Effect of Actonel on Periodontal Health of Postmenopausal Women

• Status: Unknown status
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospitals Cleveland Medical Center
• Treatments: Risedronate Sodium; Risedronic Acid

Criteria

Inclusion Criteria:

• Osteopenia

• Postmenopausal

Exclusion Criteria:

• Male

• Diabetes